Mutations in the copper/zinc superoxide dismutase (SOD1) gene produce an an
imal model of familiar amyotrophic Lateral sclerosis (ALS), a fatal neurode
generative disorder., To test a new therapeutic strategy for ALS, we examin
ed the effect of caspase inhibition in transgenic mice expressing mutant hu
man SOD1 with a substitution of glycine to alanine in position 93 (mSOD1(G9
3A)). Intracerebroventricular administration of zVAD-fmk, a broad caspase i
nhibitor. delays disease onset and mortality. Moreover, zVAD-fmk inhibits c
aspase-1 activity as well as caspase-1 and caspase-3 mRNA up-regulation, pr
oviding evidence for a non-cell-autonomous pathway regulating caspase expre
ssion. Caspases play an instrumental role in neurodegeneration in transgeni
c mSOD1(G93A) mice, which suggests that caspase inhibition may have a prote
ctive role in ALS.